NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
About
This notice of funding opportunity (NOFO) invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. This mechanism may also be used to support development of a new resource to the broader scientific community of the National Institute of Allergy and Infectious Diseases (NIAID). It is anticipated that the request for resource support through the R24 activity code will occur on an infrequent basis and only in circumstances where other mechanisms of support from the NIAID are not appropriate. The proposed resources should be relevant to the scientific areas of the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases.
The NIAID Resource-Related Research Projects (R24) grant supports investigator-initiated proposals that develop or enhance research resources benefiting the broader scientific community and currently funded high-priority projects within the National Institute of Allergy and Infectious Diseases mission areas. This funding mechanism is ideal for researchers and institutions seeking to establish coordinated support systems, databases, biorepositories, animal models, computational tools, or other infrastructure that advances understanding of infectious diseases, immune function, allergies, asthma, and transplant rejection. Applicants should note that clinical trials are not permitted under this mechanism. The R24 is awarded on an infrequent basis and only when other NIAID funding mechanisms are insufficient. Resources must align with NIAID's scientific priorities, including microbe biology and pathogenesis, host immune responses, HIV research, vaccine and therapeutic development, and diagnostic innovation. This grant is particularly suited for established research institutions, universities, and organizations capable of managing complex research infrastructure and providing sustained support to the scientific community. Researchers with innovative resource concepts that would benefit multiple high-priority projects should carefully review the Notice of Funding Opportunity (NOFO) to determine alignment with current NIAID priorities and submission requirements.
Funding Facts
● Applications openDeadline
May 25, 2029
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2029-05-25
Grant Type
federal
Application Cycle
Infrequent - awarded on limited basis when other NIAID mechanisms are insufficient
Best For
Research institutions, universities, and established organizations developing research infrastructure and resources supporting allergy, immunology, and infectious disease research
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Frequently Asked Questions
Who is eligible for NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)?
Eligible applicants must be U.S.-based organizations and institutions. Foreign organizations and non-domestic components of U.S. organizations are not eligible to apply, though foreign components of U.S. organizations may participate. Refer to Section III of the official NOFO for complete eligibility criteria, including specific institutional requirements and other conditions.
How much funding does NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) provide?
Specific funding amounts are not specified in the current NOFO announcement. Funding levels vary by cycle and resource proposal scope. Applicants should contact NIAID or consult the full NOFO for anticipated budget ranges and financial parameters for the current funding cycle.
How do I apply for NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)?
Applications must be submitted in accordance with NIH application procedures outlined in the NOFO. Applicants should visit the official NIAID website and the NIH Grants and Funding portal (grants.nih.gov) for current submission guidelines, required forms, and institutional registration requirements. The submission deadline is May 25, 2029. Early engagement with your institutional grants office is strongly recommended.
What can NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) funding be used for?
R24 funding supports development or enhancement of research resources that benefit currently funded high-priority NIAID projects and the broader scientific community. Eligible uses include creating coordinated support systems, databases, biorepositories, reagent repositories, animal models, computational platforms, and other infrastructure. Resources must address NIAID mission areas: microbe biology and pathogenesis, immune function and dysfunction, HIV research, vaccine and therapeutic development, and diagnostic innovation. Clinical trials are not allowed under this mechanism.
Last updated: July 5, 2026